Time	Events	Chairs & Speakers
8:30 - 8:50	Registration
8:50 - 9:00	Opening Remark	Yong Sang Song (Seoul National University)
Session 1 - Chair: Yong Li (University of New South Wales)
9:00 - 9:20	Discovery of novel urine exosomal biomarkers for prostate cancer diagnosis and prognosis	Yong Li (University of New South Wales)
9:20 - 9:40	Molecular Targets of Mammary Cancer Prevention by Withanolides	Shivendra Singh (University of pittsburgh)
9:40 - 10:00	Lessons learned from mouse modeling for human pancreatic cancer	Gloria H. Su (Columbia University Medical Center)
10:00 - 10:20	Oncogenic Addiction Mechanisms in Women's Cancer	Pradeep Chaluvalli Raghavan (University of Milwaukee )
10:20 - 10:40	Coffee break
Session 2 - Chiar: Massoud Mirshahi (Universite Paris Diderot)
10:40 - 11:00	Interleukin-1β is an important HLA-G inducing factors in ovarian carcinomatosis	Massoud Mirshahi (Universite Paris Diderot)
11:00 - 11:20	Pathogenic Epigenetic Consequences of Genetic Alterations in IDH wild-type Glioma	Yutaka Kondo (Nagoya University Graduate School of Medicine)
11:20 - 11:40	Celastrol for Prevention/treatment of Obesity Associated Colorectal Cance	Chinthalapally V Rao (University of Health Sciences Center)
11:40 - 12:00	Mechanism of Nitric Oxide's in Poor Prognosis of Breast Cancer	David Wink (National Cancer Institute)
12:00 - 13:20	Lunch
Session 3 - Chair: Ciro Isidoro (Universita del Piemonte Orientale)
13:20 - 13:40	Glucose availability promotes cancer cell migration: molecular pathways and epigenetic regulations	Ciro Isidoro (Universita del Piemonte Orientale)
13:40 - 14:00	Towards precision cellular immunotherapy for multiple myeloma	Michael Firer (Ariel University)
14:00 - 14:20	Translational potential of a small molecule silibinin in colon cancer chemoprevention by targeting cancer stem cells and their inflammatory milieu	Rajesh Agarwal (University of Colorado Anschutz Medical Campu)
14:20 - 14:40	Coffee break
Session 4 - Chiar: Malyn Ungsurungsie (Chiang Mai Univeristy)
14:40 - 15:00	A multi-omics appaoach to deciphering early colonic neoplasia	Daniel W. Rosenberg (University of Connecticut School of Medicine)
15:00 - 15:20	A mesothelioma cancer stem cell survival factor	Richard L. Eckert (University of Maryland School of Medicine and Greenbaum Cancer Center)
15:20 - 15:40	Genetic variants of hereditary tumors with ovarian cancer patients in Japanese	Akira Hirasawa (Okayama University)
15:40 - 16:00	Spatially resolved transcriptomics using PHLI-seq within the tissue context	Sung Hoon Kwon (Seoul National University)
16:00 - 16:20	Coffee break
Session 5 - Chair: Danny Dhanasekaran (University of Oklahoma Health Sciences Center))
16:20 - 16:40	Coding and Non-coding Transcriptomic Analysis in Ovarian Cancerr	Danny Dhanasekaran (University of Oklahoma Health Sciences Center)
16:40 - 17:00	SPHK1 is a novel target of metformin in ovarian cancer	Tatsuyuki Chiyoda (Keio University)
17:00 - 17:20	Genomic tools for precision medicine of breast cancer	Wonshik Han (Seoul National University)
17:20 - 17:40	Conditional relative survival of cervical cancer : a Korean Central Cancer Registry Study	Jae Man Bae (Hanyang University)
17:40	Closing remark

Time	Events	Chairs & Speakers
8:00 - 8:40	Registration
Session 6 - Chair: Li Li Ji (University of Minnesota)
8:40 - 9:00	Molecular Mechanism of Muscle Disuse Atrophy	Li Li Ji (University of Minnesota)
9:00 - 9:20	Targeting RHBDL2-SLC1A5 axis to overcome chemoresistance and progression in triple negative breast cancer	Toyomasa Katagiri (Tokushima University)
9:20 - 9:40	Acute Inflammation on Cancer on Surgeon’s View	Ho-Seong Han (Seoul National University)
9:40 - 10:00	Clinically applicable RNA-ISH method for quantitative analysis of exon 2 skipping variant of AIMP2	Yoosik Kim (KAIST)
10:00 - 10:20	Cardiac Glycosides as Personalized Anti-Cancer Agents in Acute Myeloid Leukemia	Marc Diederich (Seoul National University)
10:20 - 10:40	Coffee break
Session 7 - Chiar: Taesung Park (Seoul National University)
10:40 - 11:00	Integrative analysis of multi-omics data in cancer studies	Taesung Park (Seoul National University)
11:00 - 11:20	Deep learning based prediction of platinum resistance in ovarian cancer	Taejin Ahn (Handong University)
11:20 - 11:40	Adjusting unexpected effect in differential expression analysis with large RNA-seq data	Jungsoo Gim (Chosun University)
11:40 - 12:00	The Frontier of Cancer Precision Medicine Trials in the United States	Heng Xie (Salubris pharmaceutical Co.,Ltd.)
12:00 - 13:20	Lunch
Session 8 - Chair: Johji Inazawa (Tokyo medical and Dental University)
13:20 - 13:40	Exploring novel cancer-related microRNAs and their diagnostic and therapeutic potentials in Personalized Cancer Medicine (PCM)	Johji Inazawa (Tokyo medical and Dental University)
13:40 - 14:00	Exploiting the Molecular Landscape of Cervical Cancer to Improve Clinical Outcomes	Katherine Moxley (University of Oklahoma)
14:00 - 14:20	Targeting the TGF-beta Signaling Pathway to Treat Myelofibrosis	Zhizhuang Joe Zhao (University of Oklahoma Health Sciences Center)
14:20 - 14:40	Preoperative Evaluation of Tumor Heterogeneity using Functional Imaging in Gynecological Malignancies	Hyun Hoon Chung (Seoul National University)
14:40 - 15:00	Coffee break
Session 9 - Chiar: Chin Kun Wang (Chung Shan Medical University)
15:00 - 15:20	Anticancer and metabolomics of propolis	Chin Kun Wang (Chung Shan Medical University)
15:20 - 15:40	Future direction for precision medicine: prediction model for ovarian cancer using clinical data and multi-omics	Yong Sang Song (Seoul National University)
15:40 - 16:20	Keynote lecture:Implementation of Cancer Precision Medicine in AI Hospital System	Yuske Nakamura (The University of Chicago)
16:20 - 16:40	Coffee break
Session 10 - Chair:Marc Pocard (Universite Paris Diderot)
16:40 - 17:00	Clinical complete response after neoadjuvant personalized anticancer treatment and benefit of surgical resection : major question for the future of individualized precision cancer medicine.	Marc Pocard (Universite Paris Diderot)
17:00 - 17:20	Seeing is Saving: The benefit of MR guided precision radiotherapy	Hyun-Cheol Kang (Seoul National University)
17:20 - 17:40	Comprehensive cellular landscape of colon cancer	Woong-Yang Park (Samsung Geniome Institute)
17:40 - 18:00	Molecular mechanism of the Aurora A and Aurora B specific inhibitor APIO-EE-9 suppresses cell growth in esophageal cancer cells	Guoguo Jin (China-US Hormel Cancer Institute)
18:00	Closing remark

Time	Events	Chairs & Speakers
8:30 - 9:00	Registration
Session 11 - Chair: Benjamin K Tsang (University of Ottawa)
9:00 - 9:20	The Role of Plasma Gelsolin (pGSN) in Immune Cell Regulation in Ovarian Cancer Chemoresistance	Benjamin K Tsang (University of Ottawa)
9:20 - 9:40	The miR-141/Hippo is a novel signaling axis in tumour-stromal crosstalk network promoting ovarian cancer metastatic colonization	David Wai CHAN (University of Hong Kong)
9:40 - 10:00	Increased proinflammatory signaling in fallopian tube epithelial cells from BRCA1 mutation carriers: potential association with altered glucocorticoid signaling	Theodore Brown (University of Toronto)
10:00 - 10:20	Targeting the b-catenin pathway in epithelial ovarian cancer	Chun Peng (York University)
10:20 - 10:40	Coffee break
Session 12 - Chiar:Meshach Asare-Werehene (University of Ottawa)
10:40 - 11:00	Pre-operative Circulating Plasma Gelsolin Predicts Residual Disease and Detects Stage One Ovarian Cancer	Meshach Asare-Werehene (University of Ottawa)
11:00 - 11:20	Targeting the immune microenvironment to improve cancer therapy: A real-time intravital characterization	Keehoon Jung (Seoul National University)
11:20 - 11:40	CtBP function in cancer as a metabolic sensor and a regulator	Lijun Di (University of Macau)
11:40 - 12:00	Application of radiogenomics to precision medicine in gynecologic cancer	Hideaki Tsuyoshi (University of Fukui)
12:00 - 13:20	Lunch
Session 13 - Chiar: Lothar Heninghausen (National Institute of Health
13:20 - 13:40	Precision genome editing	Lothar Heninghausen (National Institute of Health)
13:40 - 14:00	Critical roles of luminal progenitor cells in creating the cytokine-rich precancerous niche for mammary tumorigenesis	Noriko Gotoh (Kanazawa University)
14:00 - 14:20	Genomics of Gastric Cancer Microenvironment	Shumpei Ishikawa (Tokyo Medical and Dental University)
14:20 - 14:40	Dynamic non-linear role of tumor-suppressor miR-204-5p in breast cancer	Hyeong-Gon Moon (Seoul National University)
14:40 - 15:00	Coffee break
Session 14 - Chiar: Tetsuya Taga (Tokyo Medical and Dental Unversity)
15:00 - 15:20	Targeted Therapy in Ovarian Cancer	Paul DiSilvestro (Women and Infant's Hospital)
15:20 - 15:40	Tracing Oncogene Rearrangements in the Mutational History of Lung Adenocarcinoma	Young Seok Ju (KAIST)
15:40 - 16:00	Development of Treatment Strategies Targeting Cancer Stem Cells	Tetsuya Taga (Tokyo Medical and Dental Unversity)
16:00 - 16:20	Cancer Stem Cell Marker Doublecortin Like Kinase Is A Therapeutic Target For Head And Neck Cancer	Sufi Thomas (University of Kansas Cancer Center)
16:20 - 16:40	Coffee break
Session 15 - Chair: Ki Baik Hahm (CHA University)
16:40 - 17:00	Concerted actions of cancer preventive kimchi for ameliorating colitis-associated cancer	Ki Baik Hahm (CHA University)
17:00 - 17:20	Tumor-selective Nanomedicine for Cancer Diagnosis and Treatment	Sophia Zi Gu (University of New South Wales)
17:20 - 17:40	Combinatorial Approaches Targeting Metabolic and Antioxidant Pathways for Cancer Prevention and Treatment	John DiGiovanni (University of Texas at Austin)
17:40 - 18:00	Characterizing Cellular Mechanisms Underlying Phenotypes using AI and Network Technologies	Sun Kim (Seoul National University)
18:00	Closing remark

Time	Events	Chairs & Speakers
8:20 - 8:40	Registration
Session 16 - Chiar: Seong-Jin Kim (Seoul National University)
8:40 - 9:00	A novel estrogen inducible E3 ligase which targets a soluble vimentin to suppresses metastasis in triple-negative breast cancer cells	Seong-Jin Kim (Seoul National University)
9:00 - 9:20	Breast cancer risk assessment and prediction in Korea	Sue Kyung Park (Seoul National University)
9:20 - 9:40	Epigenetic modification and cancer	Tae-Young Roh (POSTECH)
9:40 - 10:00	Using imputed genotype data in the joint score tests for genetic association and gene?environment interactions in case-control studies	Minsun Song (Sookmyung Women’s University)
10:00 - 10:20	Blockchain and Real World Data	Eunsol Lee (MediBloc)
10:20 - 10:40	Coffee break
Session 17 - Chair: Young-Joon Surh (Seoul National University)
10:40 - 11:00	Nrf2-mediated antioxidant gene expression promotes breast cancer cell stemness	Young-Joon Surh (Seoul National University)
11:00 - 11:20	Is WT1 gene a tumor suppressor or oncogene?	Zigang Dong (University of Minnesota)
11:20 - 11:40	Acquisition and augmentation of cancer stem cell-like properties in polymer thin film-induced tumor spheroids	Sangyong Jon (Seoul National University)
11:40 - 12:00	Hox genes as a strategy for overcoming platinum resistance in epithelial ovarian cancer	Yong Beom Kim (Seoul National University)
12:00 - 13:20	Lunch
Session 18 - Chair: Jung Weon Lee (Seoul National University)
13:20 - 13:40	Precision chemotherapy for pediatric leukemia: star allele vs. gene-wise variant burden analyses for predicting 6-MP intolerance	Ju Han Kim (Seoul National University)
13:40 - 14:00	Deep learning method for finding ALS causal SNPs	Jinwook Choi (Seoul National University)
14:00 - 14:20	Technology developments in cancer liquid biopsy	Duhee Bang (Yonsei University)
14:20 - 14:40	TM4SF5 as a new HCC Target?	Jung Weon Lee (Seoul National University)
14:40 - 15:00	Coffee break
Session 19 - Chair: Chae Hyeong Lee (Dongguk University)
15:00 - 15:20	Microbiome-based Personalized Medicine	Yoon-Keun Kim (MD Healthcare)
15:20 - 15:40	Tumor evolution and ecology in the era of precision medicine	Tae-Min Kim (The Catholic University)
15:40 - 16:00	Precision Hematology: Current and Future	Youngil Koh (Seoul National University)
16:00 - 16:20	How can we improve the outcomes for Pancreatic cancer from basic research to clinical application ?	Joon Seong Park (Yonsei University)
16:20 - 16:40	Coffee break
Session 20 - Chair: William Au (University of Medicine and Pharmacy, Tirgu Mures)
16:40 - 17:00	Involvement of inherent DNA repair variations in the development, prevention, intervention and prognosis of cancer	William Au (University of Medicine and Pharmacy, Tirgu Mures)
17:00 - 17:20	Personalized treatment for cancer at epigenetic level	Alberto Izzotti (University of Genoa)
17:20 - 17:40	CRISPR/Cas9-mediated generation of model animals in avian species	Hong Jo Lee (Seoul National University)
17:40 - 18:00	A New Generation of Environmental Medicine: Toxicogenomic Approach for Predicting the Potential Biomarkers of Environmental Cancer for Future Health Care H Young Rok Seo (Dongguk University) ealth Care	Young Rok Seo (Dongguk University)
18:00	Closing remark